Preliminary assessment of differential expression of candidate genes associated with atherosclerosis

Genes and Genetic Systems

Volumn 88, Issue 3, 2013, Pages 199-209

  Blin, Joan ^a   Ahmad, Zalinah ^a   Lekhraj Rampal, Gyanchand Rampal ^a   Mohtarrudin, Norhafizah ^a   Tajudin, Abdul Karim Haji ^b   Adnan, Rohayu Shahar ^c  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Hospital Serdang   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

Atherosclerosis; Candidate genes; Differential gene expression; Genomelab genetic analysis system

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CYSTATHIONINE BETA SYNTHASE; GELATINASE B; INSULIN RECEPTOR SUBSTRATE 1; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN P53; THROMBOMODULIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN GENE; ARTERY CALCIFICATION; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTATHIONINE BETA SYNTHASE GENE; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; INSULIN RECEPTOR SUBSTRATE 1 GENE; LECITHIN CHOLESTEROL ACYLTRANSFERASE GENE; LIPOPROTEIN LIPASE GENE; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MALAYSIAN; MALE; MATRIX METALLOPEPTIDASE 9 GENE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; NUCLEOTIDE SEQUENCE; THROMBOMODULIN GENE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR II GENE;

ADULT; CORONARY ARTERY DISEASE; CORONARY VESSELS; GENE EXPRESSION PROFILING; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALAYSIA; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, LDL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884339541     PISSN: 13417568     EISSN: 18805779     Source Type: Journal    
DOI: 10.1266/ggs.88.199     Document Type: Article

References (36)

1. Ayyobi, A. F., McGladdery, S. H., Chan, S., Mancini, G. B. J., Hill, J. S., and Frohlich, J. J. (2004) Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up. Atherosclerosis 177, 361-366.
2. Baroni, M. G., D'Andrea, M. P., Montali, A., Pannitteri, G., Barillà, F., Campagna, F., Mazzei, E., Lovari, S., Seccareccia, F., Campa, P. P., et al. (1999) A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 19, 2975-2980.
3. Beiras-Fernandez, A., Angele, M. K., Koutang, C., Lohse, P., Reichart, B., Lohse, P., and Eifert, S. (2011) Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view. Inflamm. Res. 60, 439-445.
4. Chan, S., Chen, J., Li, Y., Lin, L., and Tsai, L. (2006) Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome. Int. J. Cardiol. 111, 280-285.
5. Chen, R., Vansant, G., Oades, K., Pickering, M., Wei, J. S., Song, Y. K., Monforte, J., and Khan, J. (2007) Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J. Mol. Diagn. 9, 80-88.
6. Drew, J. E., Mayer, C. D., Farquharson, A. J., Young, P., and Barrera, L. N. (2011) Custom design of GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue. J. Mol. Diagn. 13, 233-242.
7. Grainger, D. J. (2007) TGF-β and atherosclerosis in man. Cardiovasc. Res. 74, 213-222.
8. Hoeg, J. M., Santamarina-Fojo, S., Berard, A. M., Cornhill, J. F., Herderick, E. E., Feldman, S. H., Haudenschild, C. C., Vaisman, B. L., Hoyt, R. F., Jr., Demosky, S. J., et al. (1996) Overexpression of lecithin: cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA. 93, 11448-11453.
9. Humphries, S. E., and Ordovas, J. M. (2001) Genetics and atherosclerosis: Broadening the horizon. Atherosclerosis 154, 517-519.
10. Ismail, M., Al-Naqeep, G., and Chan, K. W. (2010) Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radical Biology & Medicine 48, 664-672.
11. Kaaman, M., Rydén, M., Axelsson, T., Nordström, E., Sicard, A., Bouloumié, A., Langin, D., Arner, P., and Dahlman, I. (2006) ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance. Int. J. Obes. 30, 447-452.
12. Kovacs, P., Hanson, R. L., Lee, Y. H., Yang, X., Kobes, S., Permana, P. A., Bogardus, C., and Baier, L. J. (2003) The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians. Diabetes 52, 3005-3009.
13. Lesauskaite, V., Ivanoviene, L., and Valanciute, A. (2003) Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects. Medicina 39, 529-534.
14. Levine, A. J., Hu, W., and Feng, Z. (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ. 13, 1027-1036.
15. Libby, P., Ridker, P. M., and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143.
16. Loftus, I. M., Naylor, A. R., Bell, P. R. F., and Thompson, M. M. (2002) Matrix metalloproteinases and atherosclerotic plaque instability. Brit. J. Surg. 89, 680-694.
17. Mallat, Z., and Tedgui, A. (2000) Apoptosis in the vasculature: mechanisms and functional importance. Br. J. Pharmacol. 130, 947-962.
18. Marutsuka, K., Hatakeyama, K., Yamashita, A., and Asada, Y. (2005) Role of thrombogenic factors in the development of atherosclerosis. J. Atheroscler. Thromb. 12, 1-8.
19. Mead, J. R., Cryer, A., and Ramji, D. P. (1999) Lipoprotein lipase, a key role in atherosclerosis? FEBS Lett. 462, 1-6.
20. Miller, D. T., Ridker, P. M., Libby, P., and Kwiatkowski, D. J. (2007) The path from genomics to therapeutics. J. Am. Coll. Cardiol. 49, 1589-1599.
21. Newby, A. C. (2007) Role of metalloproteinases in plaque rupture. Int. J. Gerontol. 1, 103-111.
22. Ohlin, A. K., Holm, J., and Hillarp, A. (2004) Genetic variation in the human thrombomodulin promoter locus and prognosis after acute coronary syndrome. Thromb. Res. 113, 319-326.
23. Rai, A. J., Kamath, R. M., and Gerald, W. (2009) Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed geneexpression profiling. Anal. Bioanal. Chem. 393, 1505-1511.
24. Rampal, L., Rampal, S., Azhar, M. Z., and Rahman, A. R. (2008) Prevalence, awareness, treatment and control of hypertension in Malaysia: A national study of 16,440 subjects. Public Health 122, 11-18.
25. Salazar, L. A., Hirata, M. H., Giannini, S. D., Forti, N., Diament, J., Lima, T. M., and Hirata, R. D. C. (2000) Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin. Chim. Acta 300, 139-149.
26. Salomaa, V., Matei, C., Aleksic, N., Sansores-Garcia, L., Folsom, A. R., Juneja, H., Park, E., and Wu, K. K. (2001) Crosssectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis 157, 309-314.
27. Seo, D., Wang, T., Dressman, H., Herderick, E. E., Iversen, E. S., Dong, C., Vata, K., Milano, C, A., Rigat, F., Pittman, J., et al. (2004) Gene expression phenotypes of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 1922-1927.
28. Spagnoli, L. G., Bonanno, E., Sangiorgi, G., and Mauriello, A. (2007) Role of inflammation in atherosclerosis. J. Nucl. Med. 48, 1800-1815.
29. Sukhova, G., Schonbeck, U., Rabkin, E., Shoen, F. J., Poole, R., Billinghurst, R. C., and Libby, P. (1999) Evidence for increased collagenolysis interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99, 2503-2509.
30. ten Dijke, P., and Arthur, H. M. (2007) Extracellular control TGFβ signalling in vascular development and disease. Nat. Rev., Mol. Cell Biol. 8, 857-869.
31. Tveten, K., Strøm, T. B., Cameron, J., Holla, Ø.L., Berge, K. E., and Leren, T. P. (2012) Characterization of a naturally occurring degradation product of the LDL receptor. Mol. Genet. Metab. 105, 149-154.
32. Vansant, G., Pezzoli, P., Saiz, R., Birch, A., Duffy, C., Ferre, F., and Monforte, J. (2006) Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture: A case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening. Int. J. Toxicol. 25, 85-94.
33. Varga, E. A., Sturm, A. C., Misita, C. P., and Moll, S. (2005) Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 111, e289-e293.
34. Wang, L., Ma, Y., Xie, X., Yang, Y., Fu, Z., Liu, F., Li, X., and Chen, B. (2011) Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China. World J. Emerg. Med. 2, 104-110.
35. Werba, J. P., Martinez, V., Abulafia, D. P., Levy, R., Magariños, G., Rey, R. H., Baetta, R., Soma, M. R., Añel, A. D., and Cuniberti, L. A. (2001) Marked neointimal lipoprotein lipase increase in distinct models of proclivity to atherosclerosis: a feature independent of endothelial layer integrity. Atherosclerosis 156, 91-101.
36. Zhao, J., Zhou, X., Huang, J., Chen, J., and Gu, D. (2005) Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population. Int. J. Cardiol. 100, 383-388.